and TCD allogeneic ACI bone marrow. Thirty-seven percent of animals repopulated as stable mixed lymphopoietic chi meras, while the remainder had no detectable allogeneic chimerism. When evaluated for evidence of donor-specific transplantation tolerance, only those recipients with detect able allogeneic lymphoid chimerism exhibited acceptance of donor-specific skin and cardiac allografts. Despite transplan tation over a major histocompatibility complex (MHC)-and minor-disparate barrier, animals accepted donor-specific ACI skin and primarily vascularized cardiac allografts per manently, while rejecting third party Brown Norway (BN) grafts. The tolerance induced was also donor-specific in vitro as evidenced by specific hyporeactivity to the allogeneic donor lymphoid elements, yet normal reactivity to MHCdisparate third party rat lymphoid cells. This model for mixed chimerism in the rat will be advantageous to investi gate specific transplantation tolerance to primarily vascular ized solid organ grafts that can be performed with relative ease in the rat, but not in the mouse, and may provide a method to study the potential existence of organ-or tissuespecific alloantigens in primarily vascularized solid organ allografts.
INTRODUCTION
In clinical transplantation, nonspecific immunosup pressive agents are required to control the rejection re sponse. In their action, these agents suppress rejection of genetically different grafts, but they also suppress other immune responses to unrelated antigens such as ACCEPTED virus or opportunistic organisms. In order to overcome these limitations, specific tolerance to allogeneic donor grafts with preservation of host immunocompetence has become a goal of transplantation today. In recent years, a number of methods have been developed to in duce donor specific transplantation tolerance using bone marrow transplantation (1, 4, 13, 14, 16, 18) . One approach, using bone marrow transplantation (BMT) with a mixture of syngeneic and allogeneic bone mar row (BM) to prepare mixed allogeneic chimeras (A + B -> A), has been shown to be effective and useful to achieve long-term donor-specific transplantation toler ance to alloantigens in mice (8) . This regimen is advan tageous over fully allogeneic (A -> B) transplantation models, because mixed chimeras exhibit superior im munocompetence to eliminate virus or produce anti body when compared with fully allogeneic chimeras due to the presence of resuisite host-type antigen pre senting cells (APCs) for T-cell activation and function (8, 17) .
Transplantation of vascularized solid organ grafts in mice has experienced limited success due to techni cal difficulties based upon vessel size. In contrast, transplantation of organs such as heart, small bowel, and liver can be performed with relative ease in the rat. Therefore, we adapted the model of mixed chimerism to the rat, which has allowed us to investigate the re sponse of mixed allogeneic chimeras to skin and pri marily vascularized solid organ.
The initial reports using allogeneic chimerism to in duce donor-specific transplantation tolerance in the Correspondence should be addressed to Peter M. Markus, M.D., Chirurgische Klinik A, Heinrich-Heine Universitat, Moorenstr. 5, 4000 Dusseldorf, Germany. mouse were preformed using congenic strain combina tions disparate only in major histocompatibility com plex (MHC), but matched for the minor region (9). When noncongenic strain combinations were utilized (BIO + C3H -> BIO), donor-specific skin grafts under went a slow chronic rejection (9) . In spite of this, ani mals remained chimeric. In addition, when congenic skin matched to the MHC of the donor (H-2 k ), but the minor antigens of the recipient (BIO) was placed, it was permanently accepted (9). This was attributed to skin-specific antigens encoded in the minor region of the genetic locus present on the skin, but not on the bone marrow cells to which the recipient was rendered tolerant, similar to those previously described for fully allogeneic chimeras (3, 21, 22) . The induction of mixed chimerism in the rat has now allowed us to evaluate whether skin-specific antigens may also exist in this species.
In our present experiments we report that stable mixed lymphopoietic chimerism can be established in the rat. Moreover, donor-specific skin and cardiac graft acceptance occurred over an MHC and non-MHC barrier to skin and primarily vascularized car diac allografts without evidence of chronic rejection for up to 150 days. This tolerance was donor-specific in vitro when evaluated by mixed lymphocyte reaction (MLR). The model of allogeneic chimerism using the rat will provide a method to study donor-specific trans plantation tolerance to other primarily vascularized allogeneic grafts, and to evaluate for potential tissue or organ-specific alloantigens.
MATERIALS AND METHODS

Animals
Male LEW (RT1 1 ), ACI (RTl a ), and BN (Rtl n ) rats (225-250 g) were purchased from Harlan Sprague-Dawley (Indianapolis, IN), and maintained in a laminar flow caging system (Thoren Caging Systems, Hazelton, PA). Animals were given acidified water containing neomycin sulfate, 10 mL per liter.
Mixed Bone Marrow
Reconstitution (LEW + ACI -> LEW) Recipient LEW animals were lethally irradiated with 1000 rad total body irradiation (TBI) delivered from a 137 Cs source. BM was har vested from tibias and femurs of ACI and LEW do nor rats, washed, and resuspended in Hanks' balanced salt solution (HBSS), supplemented with gentamicin 30 /xL/mL. T-cell depletion was performed using mag netic polymer beads (Dynabeads M4501, Bioproducts for Science, Indianapolis, IN) coated with MAb OX-19 (anti-CD5). Beads were prepared by incubating the magnetic particles with fetal bovine serum (FCS) (Gibco, Grand Island, NY), at 290 ixU FCS/mL of beads for 24 h, followed by OX-19 (29 /d/mL of beads) for 24 h. ACI and LEW BM inocula were separately T-cell depleted using a ratio of beads/T cell of 1:20 for ACI and 1:40 for LEW cells. The beads/marrow mix ture was incubated at room temperature for 30 min with constant gentle rotation. Separation of the beads/T cell complex from the depleted marrow was achieved by placing the beads/marrow mixture in a magnetic field. Flow cytometric analysis on spleen controls were performed routinely to assess successful depletion of OX-19 (anti-CD5) positive T cells. Mixed allogeneically reconstituted animals received 7 x 10 6 syngeneic TCD bone marrow cells and 43 x 10 6 allogeneic TCD bone marrow cells. Such animals will be referred to as mixed allogeneic, or LEW + ACI ->LEW. Syngeneically re constituted controls received 50 x 10 6 TCD syngeneic bone marrow cells (LEW -»LEW). Radiation controls were performed simultaneously to confirm the ade quacy of the lethal dose of irradiation.
Assessment of Chimerism by Flow Cytometry
Four weeks after reconstitution, rats receiving a mixed syngeneic + allogeneic BMT were assessed for the presence of allogeneic donor type (ACI) cells. In typing for chimerism, mAb were used to detect MHC Class I antigens. Monoclonal antibody 163 (Ig G2b) is specific for the RT1.A 1 antigen on LEW cells, whereas mAb 211 (Ig G2b) is specific for the RT1 .A a antigen on ACI cells (7, 11) . MAb 42 (RTl.A") was used as an irrelevant control (mAb 163, 211, and 42 were kindly provided by H.W. Kunz, University of Pittsburgh, Department of Pathology, Pittsburgh, PA). All three antibodies were tested against each strain used with no detectable cross reactivity. For surface marker analy sis, 1 x 10 5 cells obtained from Ficoll Hypaque gradi ent centrifugation of peripheral blood, were placed in 100 mL of HBSS. The MAbs 163, 211, and 42 were added as primary biotinylated antibodies at 1:50 dilu tion, and incubated for 60 min at 4°C. The cells were washed twice with HBSS and 0.1 % gelatin, and resus pended in fluorescein isothiocyanate (FITC) as a sec ondary marker. After 1 h at 4°C, cells were washed three times with HBSS and 0.1% gelatin, and resus pended in 1% paraformaldehyde.
Skin Grafting
Full thickness skin grafts were prepared using a modification of the method of Billingham (2). Full
thickness tail skin of donor (ACI), third party (BN)
and host-type (LEW), were placed on the panniculus carnosus of the posterior and lateral thoracic wall.
Rejection was diagnosed when 90% of the graft was necrotic.
Cardiac
Transplantation A heterotopic abdominal heart transplantation model was used in these experiments (15) . Briefly, ACI donor animals were anesthetized and heparinized with 150 units heparin IV. The thoracic cavity was opened, and the IVC and the SVC were Iigated and divided. The aorta and pulmonary artery were transected 3-5 mm distally to their origins. A mass ligature was placed around the pulmonary vein, and the heart was then re moved and stored at 4°C in cold Ringers lactate. The recipient vena cava and abdominal aorta were oc cluded, and an aortotomy and venotomy were per formed. End-to-side anastomosis of the aorta to the recipient abdominal aorta, and of the pulmonary ar tery to the recipient vena cava were completed. Sur vival of recipient animals, and skin and cardiac grafts were calculated by the life table method (6) .
Mixed Lymphocyte
Reaction (MLR) MLR assays were performed by a modified method as previously described (9) . Briefly, lymph nodes were removed under sterile conditions, and an ACK lysed single cell suspension prepared in RPMI medium con taining 0.75°7o fresh normal rat serum, 1 mM glutamine, 0.05 mM 2-mercaptoethanol, 0.1 mM nonessential amino acids, 1 mM Na-pyruvate, and 0.27°7o gentamicin (all from GIBCO). Two x 10 5 stimulator cells (2000 rad) and 1 x 10 5 responder cells, each in a vol ume of 100 ixL were placed in the 96-well, round bot tom Linbro plate (Flow Lab., McLean, VA). Cultures were incubated at 37° in 5°7o C0 2 for 4 days, pulsed on the third day with 1 /xCi of [ 3 H] Thymidine (New England Nuclear, Boston, MA) harvested 18 h later, and counted in a beta scintillation counter (Beckman, Palo Alto, CA).
RESULTS
T-Cell Depletion Using Beads
Titrations were performed to determine the optimal number of beads required to achieve TCD of the rat allogeneic ACI cells) were given to each recipient.
Survival Of Mixed Allogeneically Reconstituted Rats
Survival of recipients of the mixed syngeneic + allo geneic bone marrow inoculum was 96% at 150 days ( Fig. 1 ). Out of this group, 37% of animals (19/52) repopulated as mixed chimeras with detectable syngeneic and allogeneic lymphoid elements. When analyzed sep arately, these animals exhibited excellent survival (93% at 150 days). Of the remaining animals, 60% (31/52) repopulated as totally syngeneic and 3% (2/52) died at a time similar to radiation controls ( Fig. 1 ). Survival of mixed chimeras was compared to that of a group of animals transplanted with TCD (LEW -» LEW) in which 100% of the transplanted animals survived more than 150 days ( Fig. 1 ).
In an attempt to achieve more reliable engraftment of allogeneic bone marrow, we performed titrations of increasing numbers of cells. When up to 200 X 10 6 TCD syngeneic + allogeneic bone marrow cells, mixed in the same 6:1 ACI to LEW ratio were infused per an imal, no improvement in allogeneic bone marrow ac ceptance resulted.
Five out of 13 (38%) of the transplanted animals repopulated as true mixed chimeras. The remaining 8 repopulated as totally syngeneic when assessed 4 wk after BMT. All radiation controls expired within 16 days.
Assessment
of Chimerism Four weeks after BMT, animals were tested for the presence of host and donor type peripheral blood lymphoid elements using flow cytometry. Cell surface phenotype of peripheral blood lymphocytes (PBL) was demonstrated using rat-anti-rat monoclonal antibod ies specific for anti-Class I staining (Fig. 2) . Animals were subsequently reevaluated at 15 and 21 wk after reconstitution to assess potential fluctuations in the percentage of chimerism throughout the study. In ar tificial titrations performed by mixing ACI and LEW lymphoid cells in varying ratios, chimerism could be detected to 0.5% donor type ACI cells by flow cyto metry staining. As shown in Table 1 , the percentage of donor type allogeneic cells varied from 0.5 to 82%. Animals with detectable mixed chimerism, as well as those that typed syngeneicaliy were analyzed for the presence of donor-specific transplantation tolerance in vivo using skin or primarily vascularized cardiac allografts. Fig. 2 . Flow cytometric analysis of cell phenotype from LEW and ACI controls, two representative chimeric animals. Four wk after bone marrow transplantation, peripheral blood lymphocytes were tested for the presence of donor type ACI lymphoid cells using mAb 163 (anti-LEW) and mAb 211 (anti-ACI) (a generous gift from Dr. HW Kunz). Overlay of staining profiles with LEW and ACI mAb is shown for LEW and ACI controls. Straining of PBL with both mAb is presented separately for chimera controls. Calculation of chimerism showed 63% ACI cells for chimera 1 and 20% donor type ACI cells for chimera 2. These animals are the same as those represented in Table 1 . Days Following ACI Skin Graft Fig. 3 . Life table survival of ACI skin grafts in mixed chimeras. Four wk after bone marrow transplantation, each animal received an ACI, LEW, and a BN full thickness skin graft. Animals which received mixed bone transplantation yet repopulated only syngeneicaliy were analyzed separately. Grafts were followed for a minimum of 150 days. All animals accepted LEW skin grafts, but rejected third party BN grafts (data not shown).
(log) FLUORESCENCE INTENSITY
Histology of Donor-Specific Skin
Grafts Skin grafts surviving for more than 150 days were examined histologically in a blinded fashion. The epi dermal-dermal architecture in the ACI grafts was sim ilar to those of LEW grafts performed as controls, with no histologic evidence suggestive of chronic rejection. No obvious cellular infiltrates or architectural changes were identified.
Survival of Cardiac Allografts in Mixed Allogenically
Reconstituted Animals: Response to a Primarily Vascularized Graft
Four weeks after BMT, six mixed allogeneically re constituted animals received a heterotopic ACI cardiac graft. Again, recipients of the mixed bone marrow in oculum, that had detectable allogeneic chimerism were analyzed separately from those animals that repopulated as totally syngeneic. All mixed chimeric animals accepted the ACI donor heart graft permanently, with all grafts beating now for more than 150 days (Fig. 4) . Syngeneically reconstituted LEW animals (« = 6) pre pared as controls that received an ACI cardiac graft rejected the graft with a time course similar to unmanipulated controls.
Donor-Specific Tolerance as Assessed In Vitro by Mixed Lymphocyte Culture Proliferative (MLR) and Cellular Cytotoxicity (CML) Assay
Animals that repopulated as true mixed lymphopoi etic chimeras were tested at 100 days post-BMT for their response to donor and third party alloantigens in MLR assays. As seen in a representative one way MLR, lymph node cells obtained from mixed chime ric animals (LEW + ACI ~> Lew) were specifically nonreactive to allogeneic donor (ACI) as well as syngeneic (LEW) stimulator cells, yet were competent to respond to MHC-disparate third party cells (Table 2) , suggest ing the presence of systemic donor-specific transplan tation tolerance.
DISCUSSION
We report here a model to achieve stable mixed allo geneic chimerism in the rat using transplantation of a mixture of TCD syngeneic plus TCD allogeneic bone marrow. Because of the lack of complement-fixing anti-rat monoclonal antibodies for T-cell depletion, immunomagnetic beads were utilized. Despite manip ulation of allogeneic cell numbers administered, only approximately 40% of animals were true mixed chime ras. Both bone marrow inocula (syngeneic plus alloge neic) were TCD prior to transplantation using mAb OX-19 to specifically deplete CD-5-positive cells. This model was then utilized to evaluate the recipients for donor-specific transplantation tolerance to skin and cardiac allografts in vivo as well as to donor lymphoid elements in vitro.
Increasing the number of transplanted cells/animal did not overcome the limitation of failure engraftment of allogeneic bone marrow. Infusion up to 200 x 10 6 BM cells per animals mixed in the same 6:1 ACI:LEW ratio did not improve either the proportion of mixed chimeric animals or the level of engraftment of allo geneic donor type cells when engraftment was achieved. It is well recognized that syngeneic bone marrow en grafts more readily with fewer numbers of cells, when compared with allogeneic BM (5, 23) . Experiments in mice have shown that T-cell depletion of the syngeneic component of the mixed bone marrow inoculum is nec essary in order to allow engraftment of the allogeneic bone marrow cells when mixed allogeneic reconstitu tion is carried out (10) . It is possible that the beaddepletion using OX-19 did not remove all syngeneic T cells that prevent allogeneic stem cell engraftment. However, we feel that this is unlikely, because flow cy tometric analysis showed complete removal of OX-19 positive T cells. The T-cell depletion protocol we ap plied was also not likely to remove stem cells, because engraftment of syngeneic BM was successful in 97% (20) . It is possible that the rat, as a recipient, exhibits a greater level of alloresistance to engraftment, because in fully xenogeneic bone marrow transplantation we have found that the mouse more readily accepts rat bone marrow than the con verse (mouse -»rat).
The presence of donor-specific transplantation tol erance was independent of the percentage of donor type cells present in the BM recipient if allogeneic chi merism was at all present. This corresponds to findings reported in mice (9), and is underscored by the low level of chimerism observed in animals 8 and 9, who exhibited donor-specific skin graft survival. Previous work has already indicated that long-term skin allo graft survival was observed only in animals exhibiting hematolymphopoietic chimerism. Experiments using mixed chimerism to achieve longterm tolerance to skin grafts were previously conducted in congenic mice strains where donor and recipient were matched for non-MHC antigens (9). Chronic skin graft rejection was reported when noncongenic mice strains were utilized with donor and recipient differing in MHC plus nonMHC antigens (9,12). Skin-specific antigens were suggested to mediate this rejection, be cause animals remained chimeric even after donorspecific skin graft rejection occurred. The existence of tissue-specific antigens expressed selectively on skin, but not the bone marrow cells to which the recipient was rendered tolerant were first reported by Boyse and Olds (3) and Steinmuller (21, 22) . Mixed allogeneic re constitution using noncongenic strain combinations (B10 + C3H -> B 10) extended these observations (9, 12) . A recent report from Mayumi and Good (12) demonstrated that rejection of skin grafts by noncon genic mouse chimeras could be prevented if spleen cells were administered with the BMT. In this model, longterm tolerance to skin grafts was established using a combined treatment with mAb, bone marrow and spleen cell transplantation, and a single dose of cyclo phosphamide. The administration of spleen cells was not necessary to induce in vitro tolerance to lymphoid cells, but was required to prolong the median survival time of the donor type skin grafts from 53 days to 118 days. Differential survival of skin and heart allografts was reported using TLI followed by allogeneic BM in fusion (19) . The presence of donor-type lymphoid cells was necessary for skin, but not for heart allograft sur vival. If this phenomenon is related to the presence of skin-specific antigens, the development of suppressor cells, or to undetectable levels of chimerism in the heart recipients remains unclear.
Interestingly, in our model for mixed chimerism in the rat, there was no evidence for chronic skin or car diac graft rejection up to 150 days post BMT. All skin grafts (10/10) and all cardiac grafts (6/6) survived de spite transplantation over a MHC plus minor antigen disparity. When examined histologically, skin grafts had no evidence for chronic rejection. Different strain combinations are being evaluated to determine whether this is a strain-specific or general effect. Because the rat may be more homogeneous in minor histocompat ibility antigens in comparison to the mouse (13, 14) , it is possible that minor disparities associated with skinspecific antigens in the mouse are not great enough in the rat to influence expression of these antigens on skin cells. Alternatively, skin-specific antigens may not be expressed in the rat.
Induction of tolerance to vascularized organ grafts in our rat model was not surprising because donor type skin grafts also survived in these chimeric animals. In contrast to skin, for the heart there has been no con vincing evidence for the presence of tissue-specific an tigens that could cause selective rejection of the heart in the presence of surviving skin grafts. Testing of dif ferent strain combinations will be necessary to evaluate survival of heart grafts in other genetic combinations.
Induction of specific tolerance in the rat supports the idea that chimerism might be a useful tool to achieve donor-specific transplantation tolerance in higher spe cies and possibly in humans. Our present model of mixed chimerism in the rat allows testing of a variety of vascularized solid organs, such as liver and small bowel, which have been performed with limited suc cess in the mouse. The existence of well characterized strain combinations in genetically inbred rats will al low the evaluation for potential organ-specific antigens in these specifically tolerant recipients.
